Envestnet Asset Management Inc Biotechnology

Envestnet Asset Management Inc

$324 Billion
Q3 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BNTX Bio N Tech Se	$26.4B	$823,000 0.0% of portfolio	8,355	Q3 2025 Reduced 20.96%
SRRK Scholar Rock Holding Corp	$1.6B	$770,000 0.0% of portfolio	20,611	Q3 2025 Added 59.89%
RARE Ultragenyx Pharmaceutical Inc.	$2.33B	$752,000 0.0% of portfolio	25,033	Q3 2025 Reduced 16.43%
QURE Uni Qure N.V.	$1.44B	$674,000 0.0% of portfolio	11,549	Q3 2025 New
ROIV Roivant Sciences Ltd.	$14.7B	$579,000 0.0% of portfolio	38,289	Q3 2025 Reduced 10.56%
FOLD Amicus Therapeutics, Inc.	$2.61B	$556,000 0.0% of portfolio	70,600	Q3 2025 Added 9.87%
TARS Tarsus Pharmaceuticals, Inc.	$1.97B	$539,000 0.0% of portfolio	9,085	Q3 2025 Reduced 12.27%
AVXL Anavex Life Sciences Corp.	$534M	$533,000 0.0% of portfolio	59,943	Q3 2025 Added 20.92%
ARWR Arrowhead Pharmaceuticals, Inc.	$4.39B	$511,000 0.0% of portfolio	14,828	Q3 2025 New
MIRM Mirum Pharmaceuticals, Inc.	$2.62B	$498,000 0.0% of portfolio	6,802	Q3 2025 Added 27.64%
DNLI Denali Therapeutics Inc.	$2.36B	$470,000 0.0% of portfolio	32,415	Q3 2025 Reduced 3.35%
NUVL Nuvalent, Inc.	$4.13B	$451,000 0.0% of portfolio	5,224	Q3 2025 Reduced 6.98%
AGIO Agios Pharmaceuticals, Inc.	$2.4B	$378,000 0.0% of portfolio	9,423	Q3 2025 Reduced 6.7%
AKRO Akero Therapeutics, Inc.	$2.51B	$367,000 0.0% of portfolio	7,740	Q3 2025 Reduced 19.42%
VRNA Verona Pharma PLC	$6.52B	$362,000 0.0% of portfolio	3,398	Q3 2025 Reduced 94.05%
WVE Wave Life Sciences Ltd.	$636M	$287,000 0.0% of portfolio	39,847	Q3 2025 Added 7.75%
VRDN Viridian Therapeutics, Inc.\De	$1.13B	$283,000 0.0% of portfolio	13,173	Q3 2025 Reduced 1.36%
RVMD Revolution Medicines, Inc.	$5.62B	$280,000 0.0% of portfolio	6,000	Q3 2025 Reduced 2.01%
ETON Eton Pharmaceuticals, Inc.	$447M	$248,000 0.0% of portfolio	11,377	Q3 2025 Reduced 50.64%
INVA Innoviva, Inc.	$1.53B	$239,000 0.0% of portfolio	13,131	Q3 2025 Added 31.01%
BCRX Biocryst Pharmaceuticals Inc	$1.34B	$225,000 0.0% of portfolio	29,713	Q3 2025 Added 185.67%
NVAX Novavax Inc	$582M	$198,000 0.0% of portfolio	22,901	Q3 2025 New
EWTX Edgewise Therapeutics, Inc.	$1.19B	$175,000 0.0% of portfolio	10,837	Q3 2025 New
CDXS Codexis, Inc.	$118M	$165,000 0.0% of portfolio	67,717	Q3 2025 Reduced 1.0%
ABSI Absci Corp	$305M	$158,000 0.0% of portfolio	52,150	Q3 2025 Reduced 32.99%
IOVA Iovance Biotherapeutics, Inc.	$418M	$136,000 0.0% of portfolio	63,048	Q3 2025 Added 32.83%
PGEN Precigen, Inc.	$812M	$136,000 0.0% of portfolio	41,343	Q3 2025 Reduced 0.06%
RZLT Rezolute, Inc.	$390M	$122,000 0.0% of portfolio	13,178	Q3 2025 New
CAPR Capricor Therapeutics, Inc.	$150M	$99,000 0.0% of portfolio	13,742	Q3 2025 New
CRBU Caribou Biosciences, Inc.	$125M	$90,000 0.0% of portfolio	38,768	Q3 2025 Reduced 87.83%
VNDA Vanda Pharmaceuticals Inc.	$248M	$83,000 0.0% of portfolio	16,822	Q3 2025 Added 6.01%
ABCL Ab Cellera Biologics Inc.	$1.14B	$80,000 0.0% of portfolio	15,914	Q3 2025 Reduced 13.09%
DRTS Alpha Tau Medical Ltd.	$272M	$62,000 0.0% of portfolio	13,765	Q3 2025 New
HUMA Humacyte, Inc.	$133M	$45,000 0.0% of portfolio	26,211	Q3 2025 New
ALLO Allogene Therapeutics, Inc.	$178M	$23,000 0.0% of portfolio	18,602	Q3 2025 Reduced 2.23%
HRTX Heron Therapeutics, Inc.	$135M	$18,000 0.0% of portfolio	14,780	Q3 2025 Reduced 19.95%
OCGN Ocugen, Inc.	$284M	$16,000 0.0% of portfolio	10,000	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.